Aromatherapy vs MLM: What the Record Actually Shows

The National Association for Holistic Aromatherapy (NAHA) defines aromatherapy as the therapeutic use of genuine, plant-derived essential oils to support physical and psychological health. Nothing in that definition mentions a product catalog, sponsorship, or a rank to climb.

In professional practice, that means: recognized training (NAHA, the Alliance of International Aromatherapists, or equivalent), working knowledge of aromatic molecule chemistry, dilution and safety protocols, and, critically, no conflict of interest between the advice given and a personal sales target.

That last part is what most clearly separates professional practice from the MLM model, as the next section shows.

Multi-level marketing (MLM) is a sales model where income comes from two sources: direct product sales, and a commission on the sales made by people you recruited (and the people they recruit in turn). Companies like doTERRA and Young Living use this model to distribute their essential oils.

The problem isn't the product: it's the economic structure. A 2018 AARP Foundation study surveying MLM participants (across all industries, not just essential oils) found that 74% of distributors lose money or make none; only 25% turn a profit, and more than half of those earn less than $5,000 a year.

That figure isn't specific to essential oils: it's a structural feature of the MLM model in general. But it partly explains why the pressure to recruit and sell can push some distributors toward exaggerating what the product they represent can actually do.

Faced with the same question, "I have joint pain, what do you recommend?", an aromatherapist and an MLM distributor don't lead the same conversation.

What stands out in both cases: it wasn't the companies themselves that invented these miracle claims, but individual distributors, often healthcare professionals, which made the false claims all the more credible to the public.

The debate over health claims often overshadows an equally real problem: what mass demand does to the plants themselves.

A 2019 study published in Nature Sustainability by Dutch and Ethiopian ecologists modeled the future of Boswellia (the tree frankincense comes from). Conclusion: under current harvesting pressure (repeated tapping, trees exploited too young, no rest periods), global frankincense production could be cut in half within 20 years, and 90% of Boswellia populations could disappear by 2070.

This isn't a problem invented to criticize MLM: it's a mass-demand problem affecting the entire essential oil supply chain. But distribution organized around growing sales volumes and recruitment targets structurally creates more pressure on supply than small-scale artisanal sourcing does.

Responsible aromatherapy cares as much about harvest traceability as about what's in the bottle.

Concretely, a professional aromatherapy consultation involves: a review of medical history and current treatments, an assessment of contraindications (pregnancy, epilepsy, skin conditions, drug interactions), a choice of molecules based on their biochemical composition rather than a plant's common name, and a dilution calculation matched to the application route and the person.

None of that depends on a supplier. It's a method, not a brand.

Aromatherapy deserves to be judged on its own merits:

• documented, verifiable plant chemistry
• safety protocols, not promises
• traceability from harvest to bottle
• a practice centered on the person, not a sales target

None of that needs a recruitment system to exist.